Revealing Masked Specificities of Human Nuclear Receptors
揭示人类核受体的隐藏特性
基本信息
- 批准号:10078820
- 负责人:
- 金额:$ 54.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-22 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY/ABSTRACT
Human Nuclear Receptor (NR) family play significant roles in critical cellular functions such as development,
metabolism, and physiology. Disruptions in their DNA binding specificities, due to either mutation in the NR or
in the associated DNA regulatory sites, have been implicated in has been implicated in several diseases
including glaucoma, cataract, retinal diseases, asthma, inflammation, autoimmune and developmental
disorders, hormonal imbalances, obesity, cancers and diabetes. Human NRs are some of the most effective
drug targets and the focus of multi-billion dollar pharmaceuticals. A comprehensive understanding of NR gene
targeting in vivo, especially when bound to different physiological ligands as well as widely prescribed drugs
that have different impact in different individuals and different cell types, will result in a highly informed
approach to drug development and deployment. State-of-the-art methods are inadequate to fully characterize
the DNA cognate sites of NRs because they often bind as cooperative homotypic or heterotypic oligomers with
other TFs. Additionally, the site preferences of NRs are modulated in non-obvious ways by certain natural
ligands and related synthetic drugs. The state-of-the-art methods also often ignore the medium-to-low
sequence specificity differences of closely related TFs, which in turn are crucial to understanding the vital
differences in the biological functions among the NRs. This project’s first aim is to develop innovative
computational approaches to elucidate the complex binding characteristics of NRs and to identify the vital
differences in binding profiles of closely related NRs. The analysis will utilize recently collected experimental
cognate site identification (CSI) data from high throughput sequencing of DNA-interactomes of all full-length
functional human NRs in the context of whole cell extracts. We also propose to rigorously evaluate the impact
of a wide-range of physiological small molecule ligands as well as prescribed therapeutics/drugs on NR-DNA
interactomes. The computationally determined sequence preferences will be experimentally tested using
biochemical, biophysical and cell biological assays. Thus we will integrate computation and experimental
validation to decipher how NRs target the genome and manifest their biological roles. Moreover, the efforts will
enable precision-medicine by defining the impact of current therapeutics in guiding NRs in the context of
individual genomes.
项目总结/摘要
人核受体(NR)家族在重要的细胞功能中发挥重要作用,
新陈代谢和生理学。由于NR突变或
在相关的DNA调控位点,已被牵连在已牵连在几种疾病
包括青光眼、白内障、视网膜疾病、哮喘、炎症、自身免疫和发育
失调、激素失衡、肥胖、癌症和糖尿病。人类的核反应堆是最有效的
药物靶点和数十亿美元的药物的焦点。对NR基因的全面认识
体内靶向,特别是当与不同的生理配体以及广泛处方的药物结合时
对不同的个体和不同的细胞类型有不同的影响,
药物开发和部署的方法。最先进的方法不足以充分表征
NR的DNA同源位点,因为它们通常作为合作的同型或异型寡聚体与
其他TF此外,NR的位置偏好以非明显的方式受到某些自然条件的调节。
配体和相关的合成药物。最先进的方法也往往忽略了中低
密切相关的转录因子的序列特异性差异,这反过来又是至关重要的了解重要的
NR之间生物学功能的差异。该项目的第一个目标是开发创新的
计算方法来阐明NR的复杂结合特性,并确定重要的
密切相关的NR的结合特征的差异。分析将利用最近收集的实验数据,
来自所有全长的DNA相互作用组的高通量测序的同源位点鉴定(CSI)数据
在全细胞提取物的情况下的功能性人NR。我们还建议严格评估
广泛的生理小分子配体以及NR-DNA上的处方治疗剂/药物
相互作用体通过计算确定的序列偏好将通过使用
生物化学、生物物理学和细胞生物学测定。因此,我们将结合计算和实验
验证以破译NR如何靶向基因组并表现出它们的生物学作用。此外,努力将
通过定义当前治疗方法在以下背景下指导NR的影响,实现精确医学
个体基因组
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hidden modes of DNA binding by human nuclear receptors.
- DOI:10.1038/s41467-023-39577-0
- 发表时间:2023-07-13
- 期刊:
- 影响因子:16.6
- 作者:Bhimsaria, Devesh;Rodriguez-Martinez, Jose A.;Mendez-Johnson, Jacqui L.;Ghoshdastidar, Debostuti;Varadarajan, Ashwin;Bansal, Manju;Daniels, Danette L.;Ramanathan, Parameswaran;Ansari, Aseem Z.
- 通讯作者:Ansari, Aseem Z.
Flexibility and structure of flanking DNA impact transcription factor affinity for its core motif.
- DOI:10.1093/nar/gky1057
- 发表时间:2018-12-14
- 期刊:
- 影响因子:14.9
- 作者:Yella VR;Bhimsaria D;Ghoshdastidar D;Rodríguez-Martínez JA;Ansari AZ;Bansal M
- 通讯作者:Bansal M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ASEEM Z ANSARI其他文献
ASEEM Z ANSARI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ASEEM Z ANSARI', 18)}}的其他基金
Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs Ataxin
刺激 Frataxin 表达以改善 Freidreichs Ataxin 的合成分子
- 批准号:
10382433 - 财政年份:2018
- 资助金额:
$ 54.74万 - 项目类别:
Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs Ataxin
刺激 Frataxin 表达以改善 Freidreichs Ataxin 的合成分子
- 批准号:
10078821 - 财政年份:2018
- 资助金额:
$ 54.74万 - 项目类别:
Revealing masked specificities of human Nuclear Receptors
揭示人类核受体的隐藏特性
- 批准号:
9356561 - 财政年份:2016
- 资助金额:
$ 54.74万 - 项目类别:
STRUCTURE AND DNA BINDING STUDIES OF NANOG, SOX2, AND OCT4
NANOG、SOX2 和 OCT4 的结构和 DNA 结合研究
- 批准号:
8361239 - 财政年份:2011
- 资助金额:
$ 54.74万 - 项目类别:
Modular design of synthetic transcriptional regulators
合成转录调节因子的模块化设计
- 批准号:
8031050 - 财政年份:2010
- 资助金额:
$ 54.74万 - 项目类别:
SYNTHESIS OF PNA-ENCODED COMBINATORIAL PEPTIDE LIBRARIES
PNA 编码的组合肽库的合成
- 批准号:
7954648 - 财政年份:2009
- 资助金额:
$ 54.74万 - 项目类别:
相似海外基金
Dehumanized cognition of masked faces
对蒙面面孔的非人化认知
- 批准号:
23K02856 - 财政年份:2023
- 资助金额:
$ 54.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Vision-based pain detection in masked faces
基于视觉的蒙面面部疼痛检测
- 批准号:
572495-2022 - 财政年份:2022
- 资助金额:
$ 54.74万 - 项目类别:
University Undergraduate Student Research Awards
Application of nanotechnology for remediation of deoxynivalenol (DON) and masked mycotoxins in wheat grains and swine feed
应用纳米技术修复小麦籽粒和猪饲料中的脱氧雪腐镰刀菌烯醇 (DON) 和隐蔽霉菌毒素
- 批准号:
569904-2022 - 财政年份:2022
- 资助金额:
$ 54.74万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
How voice familiarity facilitates intelligibility of degraded and masked speech
语音熟悉度如何促进降级和屏蔽语音的清晰度
- 批准号:
RGPIN-2017-05587 - 财政年份:2022
- 资助金额:
$ 54.74万 - 项目类别:
Discovery Grants Program - Individual
Abrasive waterjet micro-machining using masked substrates
使用掩模基材的磨料水射流微加工
- 批准号:
574430-2022 - 财政年份:2022
- 资助金额:
$ 54.74万 - 项目类别:
University Undergraduate Student Research Awards
A Pilot Masked, Randomized Controlled Trial Evaluating Locally-applied Gentamicin versus Saline in Open Tibia Fractures (pGO-Tibia)
一项蒙蔽随机对照试验,评估局部应用庆大霉素与生理盐水治疗开放性胫骨骨折 (pGO-Tibia)
- 批准号:
10191765 - 财政年份:2021
- 资助金额:
$ 54.74万 - 项目类别:
A Pilot Masked, Randomized Controlled Trial Evaluating Locally-applied Gentamicin versus Saline in Open Tibia Fractures (pGO-Tibia)
一项蒙蔽随机对照试验,评估局部应用庆大霉素与生理盐水治疗开放性胫骨骨折 (pGO-Tibia)
- 批准号:
10392433 - 财政年份:2021
- 资助金额:
$ 54.74万 - 项目类别:
Novel masked mycotoxins~glucoside conjugates of trichothecenes and their risks for food
新型隐蔽霉菌毒素~单端孢霉烯族葡萄糖苷结合物及其食品风险
- 批准号:
21K05428 - 财政年份:2021
- 资助金额:
$ 54.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SELF-MASKED ALDEHYDES AS INHIBITORS OF THE CYSTEINE PROTEASES 3CL PROTEASE, CATHEPSIN L, AND CRUZAIN
自掩蔽醛作为半胱氨酸蛋白酶 3CL 蛋白酶、组织蛋白酶 L 和 CruzAIN 的抑制剂
- 批准号:
10355007 - 财政年份:2021
- 资助金额:
$ 54.74万 - 项目类别:
A Pilot Masked, Randomized Controlled Trial Evaluating Locally-applied Gentamicin versus Saline in Open Tibia Fractures (pGO-Tibia)
一项蒙蔽随机对照试验,评估局部应用庆大霉素与生理盐水治疗开放性胫骨骨折 (pGO-Tibia)
- 批准号:
10604256 - 财政年份:2021
- 资助金额:
$ 54.74万 - 项目类别: